CLINICAL IMMUNOLOGY
Subpopulations of natural killer-T-like cells before and after surgical treatment
of laryngeal cancer
More details
Hide details
Submission date: 2016-07-07
Final revision date: 2016-09-18
Acceptance date: 2016-09-20
Publication date: 2017-10-30
Cent Eur J Immunol 2017;42(3):252-258
KEYWORDS
ABSTRACT
Introduction: Tumours connected with head and neck comprise about 5% of all tumours. The most frequent histological type of laryngeal carcinoma is squamous cell carcinoma. Different research projects suggest that the role of T lymphocytes might be significant in tumour development. iNKT cells are a new subpopulation of T cells and show cytotoxic activity against tumours. iNKT cells participate in modulating the function of other cells which have anti-tumour properties and secrete cytokines, which have pro-inflammatory and anti-inflammatory effects. In animal models the significance of iNKT cells in various diseases including cancer was shown.
Aim of the study: The aim of this study was to determine the percentages of iNKT cells, CD161+ cells, CD161– cells, iNKT CD4+ cells, and iNKT CD8+ cells, NK cells, NKT-like cells, and T cells subsets present in peripheral blood of patients with laryngeal cancer before and two months after the tumour resection, in comparison to healthy volunteers.
Materials and methods: This study included material from laryngeal patients who were treated at the Department of Otolaryngology and Laryngological Oncology (Medical University of Lublin) between 2012 and 2013. A total of 50 patients (40 men and 10 women) aged between 45 and 77 years (median age: 60 years) were enrolled. Based on the TNM classification, the patients were classified as having stage I-IV laryngeal cancer. The control group was composed of 15 healthy volunteers (12 men and three women) aged between 43 and 82 years (median age: 61 years). The protocol of the study was approved by the Local Bioethical Committee at the Medical University of Lublin.
Peripheral blood samples (15 ml) from the basilic vein were collected by venipuncture using sterile, sodium heparin-treated tubes (20 units per ml of blood) and used for cytometric analyses.
Results: iNKT cells were analysed among T CD3+ cells. The percentage of CD3+ and CD3+CD4+ T cells before tumour resection was higher than in the control group, but the increase of CD3+ T cells was not significant. The T CD3+CD4+ / T CD3+CD8+ cell ratio was significantly higher than in healthy donors. After tumour resection a decreased percentage of CD3+CD4+ T cells but an increased percentage of CD8+CD3+T cells was noted. The T CD3+CD4+ / T CD3+CD8+ cell ratio was significantly higher in patients before and after the surgery than in the control group. The amount of NKT-like cells increased after resection and was significantly higher than in the control group.
Conclusions: Our study exhibited the change in percentage of iNKT, NK, NKT-like cells, and T lymphocytes after tumour resection in patients with laryngeal cancer. The research explains the contribution of those cells in immunological response against tumour.
REFERENCES (27)
1.
Reuter CW, Morgan MA, Eckardt A (2007): Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neck. Br J Cancer 96: 408-516.
2.
Pantel M, Guntinas-Lichius O (2012): Laryngeal carcinoma: epidemiology, risk factors and survival. HNO 60: 32-40.
3.
Kardasz-Ziomek M, Scierski W, Namyslowski G, et al. (2012): Long term results of partial laryngectomies in patients suffering from laryngeal cancer. Otolaryngol Pol 66: 46-50.
4.
Klatka J, Grywalska E, Wasiak M, et al. (2016): The percentage of iNKT cells among other immune cells at various clinical stages of laryngeal cancer. Postepy Hig Med Dosw 70: 392-399.
5.
Sharma AA, Chew L, Ladd M, et al. (2011): Ex vivo purification and characterization of human invariant natural killer T cells. J Immunol Methods 373: 1-7.
6.
Rogers PR, Matsumoto A, Naidenko O, et al. (2004): Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000. J Immunol Methods 285: 197-214.
7.
Zdrazilova- Dubska L., Valik D, Budinska E, et al. (2012): NKT- like cells are expanded in solid tumour patients. Klin Oncol 25: 2S21-2S25.
8.
Terabe M, Berzofsky JA (2014): The immunoregulatory role of type I and type II NKT cells in cancer and other diseases. Cancer Immunol Immunother 63: 199-213.
9.
Metelitsa LS (2004): Flow cytometry for natural killer T cells: multi-parameter methods for multifunctional cells. Clin Immunol 110: 267-276.
10.
Grywalska E, Markowicz J, Siwicka D, et al. (2013): Natural killer and natural killer T-like cells in splenectomised patients. Centr Eur J Immunol 38: 372-379.
11.
Chen W, Wang X, Tao R (2011): Analysis of serum T-lymphocyte subsets and NK cell activity in patients with squamous cell carcinoma of pharynx and larynx [Abstract]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 25: 1105-1107.
12.
Kou F, Qi S (2001): Changes of NK cell’s activity and T lymphocyte subpopulation in peripheral blood of patients with laryngocarcinoma [Abstract]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 15: 505-506.
13.
Sakakura K, Chikamatsu K, Takahashi K, et al. (2006): Maturation of circulating dendritic cells and imbalance of T cell subsets in patients with squamous cell carcinoma of the head and neck. Cancer Immunol Immunother 55: 151–159.
14.
Li Y, Che Z, Liang M (1997): Study on the immune state of patients with laryngeal carcinoma [Abstract]. Lin Chuang Er Bi Yan Hou Ke Za Zhi 11: 69-72.
15.
Ritoe SC, de Vegt F, Scheike IM, et al. (2007): Effect of routine follow-up after treatment for laryngeal cancer on life expectancy and mortality: results of a Markov model analysis. Cancer 109: 239-247.
16.
Klatka J, Grywalska E, Klatka M, et al. (2013): Expression of CD200 and CD200R regulatory molecules on the CD83+ monocyte-derived dendritic cells generated from patients with laryngeal cancer. Folia Histochem Cytobiol 51: 59-65.
17.
Perlabo E, Alonso C, Solana R (2007): Invariant NKT and NKT-like lymphocytes: Two different T cell subsets that are differentially affected by ageing. Exp Gerontol 42: 703-708.
18.
Balato A, Unutmaz D, Gaspari AA (2009): Natural killer T cells: an unconventional T-cell subset with diverse effector and regulatory functions. J Invest Dermatol 129: 1628-1642.
19.
Ambrosino E, Berzofsky JA, Terabe M (2008): Regulation of tumor immunity: the role of NKT cells. Expert Opin Biol Ther 8: 725-734.
20.
Moretta L, Montaldo E, Vacca P, et al. (2014): Human natural killer cells: origin, receptors, function, and clinical applications. Int Arch Allergy Immunol 164: 253–264.
21.
Metelitsa LS (2011): Anti-tumor potential of type-I NKT cells against CD1d-positive and CD1d-negative tumors in humans. Clin Immunol 140: 119–129.
22.
Motohashi S, Okamoto Y, Yoshino I, et al. (2011): Anti-tumor immune responses induced by iNKT cell-based immunotherapy for lung cancer and head and neck cancer. Clin Immunol 140: 167–176.
23.
Carnaud C, Lee D, Donnars O, et al. (1999): Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163: 4647-50.
24.
Molling JW, Langius JA, Langendijk JA, et al. (2007): Low levels of circulating invariant natural killer T cells predict poor clinical outcome in patients with head and neck squamous cell carcinoma. J Clin Oncol 25: 862-868.
25.
Singh AK, Gaur P, Das SN (2014): Natural killer T cell anergy, costimulatory molecules and immunotherapeutic interventions. Hum Immunol 75: 250-260.
26.
Takahashi T, Dejbakhsh-Jones S, Strober S (2006): Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176: 211-216.
27.
Kuss I, Hathaway B, Ferris RL, et al. (2004): Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck. Clin Cancer Res 10: 3755-3762.